Education
About Us
Working with TipRanks
Follow Us
Onkure Therapeutics, Inc. (OKUR)
:OKUR
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | - | - | - | - | - |
| Operating Income | $ -83.05M | $ -53.85M | $ -39.82M | $ -19.55M | $ -15.47M |
| EBITDA | $ -77.22M | $ -51.87M | $ -39.52M | $ -19.52M | $ -15.44M |
| Net Income | $ -77.39M | $ -51.95M | $ -39.77M | $ -19.46M | $ -12.44M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 107.44M | $ 108.18M | $ 154.02M | $ 55.22M | $ 25.50M |
| Total Debt | $ 973.00K | $ 1.46M | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -101.99M | $ -99.71M | $ -147.67M | $ -53.61M | $ -24.89M |
| Total Liabilities | $ 18.83M | $ 8.21M | $ 6.81M | $ 97.34M | $ 48.63M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -63.90M | $ -47.71M | $ -38.18M | $ -18.56M | $ -12.52M |
| Operating Cash Flow | $ -63.68M | $ -47.36M | $ -37.98M | $ -18.54M | $ -12.51M |
| Investing Cash Flow | |||||
| Financing Cash Flow |